VitaNova Life Sciences (VNOV) EBITDA Margin (2017 - 2026)
VitaNova Life Sciences (VNOV) posted EBITDA Margin of 6.59% for Q1 2026, down 71.64% on a QoQ basis from 23.22% in Q4 2025, and down 2873.0% year-over-year from 0.24% in Q1 2025.
VitaNova Life Sciences (VNOV) EBITDA Margin (2017 - 2026) Analysis & Trends
VitaNova Life Sciences' EBITDA Margin history runs 7 years deep, the most recent figure standing at 6.59% for Q1 2026.
- Quarterly EBITDA Margin fell 2873.0% year-over-year to 6.59% in Q1 2026, while the trailing twelve-month figure through Jan 2026 was 37.44% (up 882.0% YoY) and the FY2025 annual result came in at 45.39%, up 936.0% from the prior year.
- EBITDA Margin was 6.59% for Q1 2026 at VitaNova Life Sciences, down from 23.22% in the prior quarter.
- Across five years, EBITDA Margin topped out at 80.74% in Q1 2022 and bottomed at 176.03% in Q1 2023.
- A 5-year average of 7.22% and a median of 21.43% in 2024 frame the typical range for EBITDA Margin.
- Annual changes were most pronounced in 2023 — EBITDA Margin sank 25677 bps — and 2024, when it surged 19882 bps.
- VitaNova Life Sciences' EBITDA Margin stood at 44.14% in 2022, then plunged by 431 bps to 146.17% in 2023, then soared by 115 bps to 21.43% in 2024, then advanced by 8 bps to 23.22% in 2025, then plunged by 72 bps to 6.59% in 2026.
- Business Quant data shows VNOV's EBITDA Margin at 6.59% in Q1 2026, 23.22% in Q4 2025, and 31.22% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 105.15 Bn | 101.18 Bn | 4.04 Bn | 2.23% |
| 2 | Cencora | 60.58 Bn | 58.40 Bn | 3.59 Bn | 1.63% |
| 3 | Cardinal Health | 53.81 Bn | 49.87 Bn | 2.50 Bn | 0.84% |
| 4 | Henry Schein | 9.71 Bn | 9.57 Bn | 1.07 Bn | 5.40% |
| 5 | Akso Health | 3.28 Bn | 3.28 Bn | - | - |
| 6 | 111 | 651.73 Mn | 572.63 Mn | 23.58 Mn | -0.01% |
| 7 | Accendra Health | 248.02 Mn | -88.86 Mn | 278.03 Mn | 2.73% |
| 8 | Edap Tms | 230.14 Mn | 215.14 Mn | 8.15 Mn | -41.35% |
| 9 | VitaNova Life Sciences | 11.51 Mn | 11.01 Mn | 316,343.00 | 6.59% |
| 10 | Cosmos Health | 9.57 Mn | 7.41 Mn | 1.38 Mn | -12.18% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 6.59% |
| Oct 31, 2025 | 23.22% |
| Jul 31, 2025 | -31.22% |
| Apr 30, 2025 | 55.41% |
| Jan 31, 2025 | 35.31% |
| Oct 31, 2024 | 21.43% |
| Jul 31, 2024 | -41.87% |
| Apr 30, 2024 | 42.73% |
| Jan 31, 2024 | 22.79% |
| Apr 30, 2023 | -146.17% |
| Jan 31, 2023 | -176.03% |
| Oct 31, 2022 | 44.14% |
| Jul 31, 2022 | 14.23% |
| Apr 30, 2022 | -59.57% |
| Jan 31, 2022 | 80.74% |
| Oct 31, 2021 | -66.65% |
| Jul 31, 2017 | 116.47% |